相关实验视频

Updated: Jun 25, 2026

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

An In Vitro Model for the Study of Cellular Pathophysiology in Globoid Cell Leukodystrophy

Published on: October 21, 2014

阿尔斯-PFN1的表达会损害iPSC衍生的微质中的囊泡降解

Salome Funes^1,2, Jonathan Jung^1,3, Del Hayden Gadd¹

¹Department of Neurology, University of Massachusetts Chan Medical School, Worcester, MA, 01605, USA.

Nature communications

|March 21, 2024

概括

突变性profilin-1 (PFN1) 通过损害微质功能,特别是脂质代谢和细胞化,导致肌缩性侧面硬化 (ALS). 恢复这些通路可能为ALS提供治疗策略.

科学领域:

神经科学是一个神经科学.
细胞生物学细胞生物学
遗传学遗传学是一个

背景情况:

微质在神经退行性疾病中至关重要,但它们的功能障碍机制尚不清楚.
肌缩性侧面硬化症 (ALS) 与profilin-1 (PFN1) 等基因的突变有关.

研究的目的:

研究与ALS相关的PFN1突变如何影响微质性质.
探索微质功能障碍在ALS病变发生中的作用.

主要方法:

使用了人类诱导的多能干细胞衍生微状细胞 (iMG),具有PFN1突变.
评估了脂质代谢,自,细胞和PFN1与酸酸-3-酸盐 (PI3P) 的结合亲和力.

主要成果:

ALS-PFN1的IMG显示脂质代谢,自和细胞化受损.
突变的PFN1表现出PI3P结合的增加,影响了自和内细胞通路.
拉帕米辛治疗在ALS-PFN1 iMGs中挽救了细胞功能障碍.

结论:

突变的PFN1对毒性功能的增益破坏了微质囊泡降解通路.
iMG是研究神经退行性疾病的一个有价值的模型.
准微质降解通路可能是ALS的治疗方法.

更多相关视频

In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages

In vitro Quantitative Imaging Assay for Phagocytosis of Dead Neuroblastoma Cells by iPSC-Macrophages

Published on: February 14, 2021

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Human Microglia-like Cells: Differentiation from Induced Pluripotent Stem Cells and In Vitro Live-cell Phagocytosis Assay using Human Synaptosomes

Published on: August 18, 2022

相关概念视频

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.